Simson Jake 4
4 · Bicara Therapeutics Inc. · Filed Sep 16, 2024
Insider Transaction Report
Form 4
Simson Jake
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-09-12+23,746→ 23,746 totalExercise: $18.00Exp: 2034-09-12→ Common Stock (23,746 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest upon the earlier of (i) August 16, 2025 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.
- [F2]Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the R.A. Capital Healthcare Fund, L.P. (the "Fund") and R.A. Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and Nexus Fund III to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.